Investing.com — BioNexus Gene Lab Corp (NASDAQ: BGLC )，一家市值447万美元的医疗实验室服务提供商，已宣布将从周一开盘起实施普通股反向拆股。此举旨在解决公司在纳斯达克规则下的最低竞价价格不足问题。根据 InvestingPro 数据，BGLC股价在过去一年下跌超过57%，目前交易价格为0.25美元。

Investing.com — BioNexus Gene Lab Corporation (BGLC)股票达到52周高点2.35美元，在动荡的市场环境中为公司标志着一个重要时刻。该公司市值为422万美元，交易价格仅为账面价值的0.45倍，同时保持着4.98倍的流动比率，显示出强劲的流动性状况。尽管达到这一峰值，但这家生物技术公司过去一年的旅程充满挑战，股票较上年同期大幅下跌62.76%。这一对比 ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

1 Day BGLC -18.40% DJIA -5.50% Russell 2K -4.37% Health Care/Life Sciences 4.56% ...

BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $4.47 million, has announced a reverse stock split of its common stock shares ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce ...

KUALA LUMPUR - BioNexus Gene Lab Corp. (NASDAQ: BGLC), a Nasdaq-listed technology company in the healthcare sector with a market capitalization of $5.88 million and annual revenue of $9.26 million ...

BioNexus Gene Lab Corp (NASDAQ:BGLC), a medical laboratory services provider with a market capitalization of $4.47 million, has announced a reverse stock split of its common stock shares, effective ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...